Morgan Stanley’s Artelo Biosciences ARTL Stock Holding History

Morgan Stanley’s Portfolio ARTL Stock Details ARTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-367	Closed	-$5.05K	–	8212
2025 Q3	$5.05K	Buy	367 +366	+36,600%	+$11.2K	﹤0.01%	7084
2025 Q2	$53	Hold	1	–	–	﹤0.01%	7760
2025 Q1	$18	Hold	1	–	–	﹤0.01%	7980
2024 Q4	$21	Hold	1	–	–	﹤0.01%	7858
2024 Q3	$22	Hold	1	–	–	﹤0.01%	7799
2024 Q2	$27	Hold	1	–	–	﹤0.01%	7696
2024 Q1	$30	Sell	1 -1	-50%	-$27	﹤0.01%	7627
2023 Q4	$56	Buy	2 +1	+100%	+$25	﹤0.01%	7630
2023 Q3	$29	Hold	1	–	–	﹤0.01%	7520
2023 Q2	$40	Hold	1	–	–	﹤0.01%	7548
2023 Q1	$46	Hold	1	–	–	﹤0.01%	7612
2022 Q4	$72	Hold	1	–	–	﹤0.01%	7714
2022 Q3	$0	Hold	1	–	–	﹤0.01%	7696
2022 Q2	$0	Hold	1	–	–	﹤0.01%	7795
2022 Q1	$0	Buy	+1	New	+$115	﹤0.01%	7950
2021 Q4	–	Hold	0	–	–	–	7968
2020 Q4	–	Sell	-1	Closed	–	–	7030
2020 Q3	$0	Buy	+1	New	+$284	﹤0.01%	6724

Other funds holding ARTL

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley's ARTL Position: Q4 2025 in Review

Morgan Stanley sold out of Artelo Biosciences (ARTL) in Q4 2025, closing a stake of 367 shares — an estimated $5.05K sold.

Morgan Stanley first reported a position in ARTL in Q3 2020 and held it in 16 quarters. The position peaked at $5.05K in Q3 2025. 8 funds tracked by Wall St. Rank hold ARTL as of Q4 2025.

Morgan Stanley reported no remaining Artelo Biosciences position as of Q4 2025 after selling out during the quarter.
Morgan Stanley sold 367 Artelo Biosciences shares in Q4 2025, an estimated $5.05K.
Morgan Stanley first reported a position in Artelo Biosciences in Q3 2020 and held it in 16 quarters.
Morgan Stanley's Artelo Biosciences position peaked at $5.05K in Q3 2025.
8 funds tracked by Wall St. Rank held Artelo Biosciences as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.